Garda Capital Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Sell |
12,265
-10,287
| -46% | -$853K | 0.02% | 22 |
|
|
2025
Q1 | $1.83M | Buy |
22,552
+8,176
| +57% | +$663K | 0.05% | 32 |
|
|
2024
Q4 | $1.29M | Buy |
+14,376
| New | +$1.29M | 0.09% | 17 |
|
|
2023
Q4 | – | Sell |
-68,410
| Closed | -$5M | – | 276 |
|
|
2023
Q3 | $5M | Buy |
+68,410
| New | +$5M | 0.23% | 3 |
|
|
2023
Q2 | – | Sell |
-30,560
| Closed | -$2.33M | – | 222 |
|
|
2023
Q1 | $2.33M | Buy |
+30,560
| New | +$2.33M | 0.11% | 5 |
|